CHU Grenoble Alpes
Grenoble, France
NCT Number: NCT04409197
During confinement, food intake can become compulsive, physical activity is significantly reduced, sleep is altered with exacerbated anxiety and stress levels and increased family violence. In some at-risk patients, mental health may even deteriorate. The temptation is great for all to take refuge in food or in front of screens. The main elements that can impact weight changes during this period of confinement are stress and anxiety, lack of physical activity, changes in eating habits, sleep disturbance and alcohol consumption.
The investigators wish to study the impact of confinement on pre-post confinement weight loss kinetics in adults included in weight reduction programs (RNPC).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Grenoble, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Time frame: 3 months
Change in waist circumference, blood pressure, percentage of lean, fluid and muscle mass before and after the confinement period
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
University Hospital, Grenoble
Other
Acronym: CO-RNPC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07647991
Adverse Events, Body Weight
Vienna, State of Vienna, Austria
View Trial DetailsNCT05345626
Comorbidities
Brønshøj, Denmark
View Trial DetailsNCT04109001
Comorbidities, Critical Care
View Trial DetailsNCT03434626
Chronic Disease, Chronic Illness
Lethbridge, Alberta, Canada
View Trial Details